Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 06 Jul 2026 for Boundless Bio, Inc., €14k. Read the official filing
Filing timeline
BuySaleKeith Crandell
Insider track record
Disclosed buys
2
Disclosed sells
2
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Keith Crandell: trading record in brief
This profile gathers the share dealings of Keith Crandell across 6 companies, led by Quanterix Corp, Twist Bioscience Corp and 908 Devices Inc. Over a trading history stretching from 9 March 2021 to 1 July 2026, the count stands at 26 filings.
The open-market side counts 2 purchases for €15.3M alongside 2 sales for €164k. Purchases outweigh sales by €15.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants and 6 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 6 July 2026, the filings show an option exercise worth €14k in Boundless Bio, Inc. The latest purchase dates back some time: it was published 979 days ago, on 12 February 2024. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Keith Crandell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
16,000 shares@ US$1.030.027% mcap29.3% of flowCommon StockSEC:0001012975-26-000622:0
▼
Same trade as the filing by ARCH Venture Fund IX, L.P., counted once · View ↗
16,000 shares@ US$2.490.066% mcap70.7% of flowCommon StockSEC:0001012975-26-000622:1
14,083 sharesCommon StockSEC:0001219039-26-000002:0
5,095 shares0Common StockSEC:0001214659-26-001352:0
11,364 sharesCommon StockSEC:0001562180-25-004804:0
4,472 shares0Common StockSEC:0001214659-25-002256:0
7,777 sharesCommon StockSEC:0001562180-24-005066:0
589,743 sharesCommon StockSEC:0000950170-24-041842:0
363,637 shares@ US$5.50100.0% of flowCommon StockSEC:0001062993-24-002841:0
Canonical exit: 8 May 2024 (T+90)
5,815 shares0Common StockSEC:0001214659-24-002246:0
1,600,000 sharesClass A Common StockSEC:0001062993-23-016234:0
4,771 sharesCommon StockSEC:0001562180-23-005309:0
1,170 shares@ US$11.1622.2% of flowCommon StockSEC:0001562180-23-003402:0
8,212 shares0Common StockSEC:0001214659-23-001899:0
8,083 shares0Common StockSEC:0001562180-23-000101:0
1,326 shares@ US$10.4826.2% of flowCommon StockSEC:0001562180-22-007043:0
893 shares@ US$16.7926.5% of flowCommon StockSEC:0001562180-22-005559:0
1,379 sharesCommon Stock, par value $0.001SEC:0001562180-22-005192:0
492 shares@ US$30.4725.1% of flowCommon StockSEC:0001562180-22-003261:0
3,491 shares0Common StockSEC:0001209191-22-008625:0
189,311 shares0Common StockSEC:0001562180-22-000232:0
189,311 shares0Common StockSEC:0001562180-21-006302:0
1,412 shares@ US$106.93100.0% of flowCommon StockSEC:0001062993-21-007502:0
▲
Same trade as the filing by Deerfield Management Company, L.P. (Series C), counted once · View ↗
1,600,000 shares@ US$10.00100.0% of flowClass A Common StockSEC:0000899243-21-031427:0
Canonical exit: 28 Oct 2021 (T+90)
213,740 shares0Common StockSEC:0001104659-21-089485:0
25 of 23 declarations
